Queens Sickle Cell Advocacy is categorized under Advocacy Group in Queens Village, NY and active since 1997.
Queens Sickle Cell Advocacy was established in 1997, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Advocacy Group business, which does work in the BOTH market, and is classified as a Advocacy Group, under code number 6219991 by the NAICS.
If you are seeking more information, feel free to contact Gloria Rochester, President at the company’s single location by writing to 20708 Hollis Avenue, Queens Village, New York NY 11429 or by phoning (718) 712-0873. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Queens Sickle Cell Advocacy |
Contact Person: | Gloria Rochester, President |
Address: | 20708 Hollis Avenue, Queens Village, New York 11429 |
Phone Number: | (718) 712-0873 |
Website Address: | qscan.org |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1997 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Advocacy Group |
SIC Code: | 8399 |
NAICS Code: | 6219991 |
Share This Business: |
Queens Sickle Cell Advocacy was started in 1997 to provide professional Advocacy Group under the SIC code 8399 and NAICS code 6219991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Gloria Rochester, President for inquiries that concern Queens Sickle Cell Advocacy by calling the company number (718) 712-0873, as your correspondence is most welcome. Additionally, the physical location of the single location of Queens Sickle Cell Advocacy can be found at the coordinates 40.70761,-73.75005 as well as the street address 20708 Hollis Avenue in Queens Village, New York 11429.
For its online presence, you may visit Queens Sickle Cell Advocacy’s website at qscan.org and engage with its social media outlets through on Twitter and on Facebook.